Muteb Alanazi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Genetic Diversity

Breast Cancer Cells

Top Venues

Antibiotics (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Amr Selim Abu Lila, Tareq Nafea Alharby, Jowaher Alanazi, Muteb Alanazi, Marwa Helmy Abdallah, Syed Mohd Danish Rizvi, Afrasim Moin, El-Sayed Khafagy, Shams Tabrez, Abdullah Ali Al Balushi, Wael A H Hegazy
Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Amr Selim Abu Lila, Tareq Nafea Alharby, Jowaher Alanazi, Muteb Alanazi, Marwa Helmy Abdallah, Syed Mohd Danish Rizvi, Afrasim Moin, El-Sayed Khafagy, Shams Tabrez, Abdullah Ali Al Balushi, Wael A H Hegazy
Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Jowaher Alanazi, Aziz Unnisa, Muteb Alanazi, Tareq Nafea Alharby, Afrasim Moin, Syed Mohd Danish Rizvi, Talib Hussin, Amir Mahgoub Awadelkareem, Abd Elmoneim O Elkhalifa, Syed Shah Mohammed Faiyaz, Mohammad Khalid, Devegowda Vishakante Gowda
3-Methoxy Carbazole Impedes the Growth of Human Breast Cancer Cells by Suppressing NF-κB Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)